Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Frontier Medicines raises $88M for R&D, including potential rival to Amgen cancer drug
MedCity News
Wed, 07/21/21 - 12:06 am
Frontier Medicines
Amgen
cancer
Lumakras
Amgen's Neulasta banner draws OPDP’s second letter of 2021
RAPS.org
Wed, 07/14/21 - 10:54 pm
Amgen
Neulasta
FDA
OPDP
advertising
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Amgen in $365m ‘smart facility’ manufacturing expansion
Biopharma Reporter
Thu, 07/1/21 - 10:30 am
Amgen
drug manufacturing
Amgen adds 400 jobs in central Ohio as part of an expansion of its packaging operations
Endpoints
Tue, 06/29/21 - 11:00 am
Amgen
hirings
drug manufacturing
Ohio
Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron
Fierce Pharma
Tue, 06/22/21 - 11:56 am
Amgen
PCSK9 inhibitors
Sanofi
Regeneron
patents
Repatha
Amgen follows Sanofi into a new dermatitis mechanism
EP Vantage
Tue, 06/1/21 - 10:58 am
Amgen
Sanofi
atopic dermatitis
Ichnos
KHK4083
Kyowa Kirin
Amgen lands first FDA approval for drug targeting elusive mutation in lung cancer
MedCity News
Sat, 05/29/21 - 04:52 pm
Amgen
FDA
sotorasib
Lumakras
KRAS mutation
Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein
Fierce Pharma
Mon, 05/17/21 - 10:59 pm
Novartis
Sandoz
generics
Supreme Court
Amgen
Embrel
biosimilar
ACC 2021: With Amgen out of the picture, Cytokinetics imagines supporting role for omecamtiv in heart failure
Fierce Biotech
Mon, 05/17/21 - 10:48 am
Amgen
Cytokinetics
ACC
Omecamtiv Mecarbil
Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent
Fierce Biotech
Thu, 05/13/21 - 10:57 am
Amgen
AstraZeneca
tezepelumab
asthma
severe asthma
Sanofi
Dupixent
FDA
Amgen asks FDA for approval of key asthma drug
BioPharma Dive
Mon, 05/10/21 - 08:15 pm
Amgen
FDA
asthma
tezepelumab
Pandemic slowed sales of cancer, arthritis, diabetes drugs
Beckers Hospital Review
Mon, 05/3/21 - 10:48 am
COVID-19
pandemic
cancer
diabetes
arthritis
Merck
Keytruda
Amgen
Enbrel
Amgen’s low-dose Kras curveball
EP Vantage
Thu, 04/29/21 - 10:40 am
Amgen
FDA
Lumakras
sotorasib
Why Amgen's Q1 Results Disappointed Investors
Motley Fool
Wed, 04/28/21 - 10:18 am
Amgen
earnings
Bristol Myers' next-gen immunology med busts Amgen's Otezla in head-to-head study. Is a showdown coming?
Endpoints
Fri, 04/23/21 - 11:12 am
Bristol Myers Squibb
biologics
psoriasis
Amgen
deucravacitinib
Otezla
The retreat of corporate venture funding?
EP Vantage
Fri, 04/23/21 - 11:02 am
funding
venture funding
venture capital
AbbVie
Amgen
Boehringer Ingelheim
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Merck KGaA
Pfizer
Roche
Sanofi
Takeda
Amgen's promising gastric cancer drug makes good on Five Prime potential with FDA's breakthrough nod
Endpoints
Tue, 04/20/21 - 11:13 am
Amgen
clinical trials
gastric cancer
bemarituzumab
FDA
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
M&A
Alexion
Amgen
AstraZeneca
Biogen
Five Prime Therapeutics
Gilead Sciences
GW Pharma
Horizon Therapeutics
Immunomedics
Jazz Pharmaceutical
Kymab
Merck
Pandion
Sanofi
Viela Bio
Anti-aging biotech upstart plucks a drug from Amgen's discard pile, pivoting from heart failure to muscle conditions
Endpoints
Wed, 04/14/21 - 09:24 am
BioAge Labs
Amgen
AMG 986
BGE-105
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »